Gerostate Alpha

A pharmaceutical company dedicated to treating aging and age-related disease

Analytics

Raised to Date: Raised: $301,335

Aggregate Commitments $
Platform

Wefunder

Start Date

07/20/2021

Close Date

04/30/2022

Min. Goal

$50,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

SAFE

Funding Type

RegCF

Series

Pre-Seed

Valuation Cap

$15,000,000

Discount Rate

10%

Rolling Commitments $
Status

Active

Reporting Date

07/28/2021

Days Remaining

276

% of Min. Goal

603%

% of Max. Goal

28%

Likelihood of Max
extremely
Avg. Daily Raise

$37,667

# of Investors

321

Momentum
cold
Log in or create a free account today to gain access to KingsCrowd analytics.
Location

Novato, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B/B2C

Margin

High

Capital Intensity

High

Business Type

Growth

Gerostate Alpha, with a $15 million valuation cap, is raising funds on Wefunder. The pharmaceutical company is making drugs that slow down tissue aging. The unbiased drug development pipeline of the company addresses multiple functional domains of aging, including cardiovascular, muscular, neurological, and metabolic. Simon Melov founded Gerostate Alpha in June 2018. The proceeds of the current crowdfunding round, with a minimum target of $50,000 and a maximum target of $1,070,000, will be used towards the eight-month study of three priority candidate compounds, personnel and equipment costs, animal purchase and housing, equipment, and animal feed and reagents. Gerostate Alpha delivers drug candidates to slow aging with a success rate of 20%. The company is currently testing its products on aging mice.
Summary Profit and Loss Statement
Most Recent Year Prior Year

Revenue

$0

$6,000

COGS

$0

$0

Tax

$1,930

$872

 

 

Net Income

$-636,728

$-920,725

Summary Balance Sheet
Most Recent Year Prior Year

Cash

$302,791

$627,109

Accounts Receivable

$0

$0

Total Assets

$415,190

$753,781

Short-Term Debt

$44,386

$51,048

Long-Term Debt

$2,389,786

$208,498,600

Total Liabilities

$2,434,172

$208,549,648

Financials as of: 07/20/2021
Log in or create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings

Analyst Report

Other Deals

Cheers on StartEngine

Alcohol consumption is one of the oldest human practices on record. A study released in…

RegCF
EnGen Bio on Wefunder

COVID-19 has brought the world’s attention to vaccine development. In April 2021, a record 4

RegCF
Audubon Bioscience on MicroVentures

In 2020 alone, companies produced, tested, and began to produce a vaccine for a completely new virus on…

RegCF
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add Gerostate Alpha on Wefunder 2021
Follow company
Follow Gerostate Alpha on Wefunder 2021
Want to learn more about Gerostate Alpha?
Join the Pre-IPO Market’s #1 Ratings & Analytics Service FREE for 7 days.
Yes! I want to start my free trial.
Already a member? Log in here.
Invest Now